INCOME TAXES (Details) (USD $)	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Expiration of Operating Loss Carryforwards and Research Credit Carryforwards [Line Items]
Consolidated operating loss carryforwards	$ 46,362,734
Research activities carryforwards	496,067
Period of cumulative changes in ownership considered for limit on operating loss and tax credit carryforwards	3 years
Minimum percentage of cumulative changes in ownership considered for limit on operating loss and tax credit carryforwards (in hundredths)	50.00%
Deferred tax assets [Abstract]
Net operating loss carryforwards	16,549,134	15,257,981
Intangible assets	305,552	363,399
Other	502,732	489,105
Total gross deferred tax assets	17,357,418	16,110,485
Deferred tax liabilities [Abstract]
Property and equipment	77,839	56,589
Total gross deferred tax liabilities	77,839	56,589
Net total of deferred assets and liabilities	17,279,579	16,053,896
Valuation allowance	(17,279,579)	(16,053,896)
Net deferred tax assets	0	0
Increase in valuation allowance	1,225,683	1,398,380
Reconciliation of expected statutory federal income tax rate to actual income tax rate [Abstract]
Expected income tax (benefit) at federal statutory tax rate -35%	(1,309,975)	(1,364,770)
Permanent differences	16,500	59,803
Research tax credits	(8,690)	(43,592)
Amortization of deferred start up costs	0	0
Valuation allowance	1,302,165	1,348,559
Income tax expense	0	0
Federal statutory tax rate (in hundredths)	35.00%
Liability for unrecognized tax benefits	0	0
2021 [Member]
Expiration of Operating Loss Carryforwards and Research Credit Carryforwards [Line Items]
Consolidated operating loss carryforwards	34,248
Research activities carryforwards	0
2023 [Member]
Expiration of Operating Loss Carryforwards and Research Credit Carryforwards [Line Items]
Consolidated operating loss carryforwards	95,666
Research activities carryforwards	0
2024 [Member]
Expiration of Operating Loss Carryforwards and Research Credit Carryforwards [Line Items]
Consolidated operating loss carryforwards	910,800
Research activities carryforwards	13,584
2025 [Member]
Expiration of Operating Loss Carryforwards and Research Credit Carryforwards [Line Items]
Consolidated operating loss carryforwards	1,687,528
Research activities carryforwards	21,563
2026 [Member]
Expiration of Operating Loss Carryforwards and Research Credit Carryforwards [Line Items]
Consolidated operating loss carryforwards	11,950,281
Research activities carryforwards	60,797
2027 [Member]
Expiration of Operating Loss Carryforwards and Research Credit Carryforwards [Line Items]
Consolidated operating loss carryforwards	3,431,365
Research activities carryforwards	85,052
2028 [Member]
Expiration of Operating Loss Carryforwards and Research Credit Carryforwards [Line Items]
Consolidated operating loss carryforwards	8,824,940
Research activities carryforwards	139,753
2029 [Member]
Expiration of Operating Loss Carryforwards and Research Credit Carryforwards [Line Items]
Consolidated operating loss carryforwards	6,889,761
Research activities carryforwards	81,940
2030 [Member]
Expiration of Operating Loss Carryforwards and Research Credit Carryforwards [Line Items]
Consolidated operating loss carryforwards	5,113,583
Research activities carryforwards	41,096
2031 [Member]
Expiration of Operating Loss Carryforwards and Research Credit Carryforwards [Line Items]
Consolidated operating loss carryforwards	3,728,626
Research activities carryforwards	43,592
2032 [Member]
Expiration of Operating Loss Carryforwards and Research Credit Carryforwards [Line Items]
Consolidated operating loss carryforwards	3,695,936
Research activities carryforwards	$ 8,690